Calcium and Its Role in Prosthodontics
Calcium and Its Role in Prosthodontics
Calcium and Its Role in Prosthodontics
PROSTHODONTICS
PRESENTED BY-
DR. SOUMIK KARMAKAR
1st YEAR PGT
DEPT. OF PROSTHODONTICS AND CROWN AND BRIDGE
GURU NANAK INSTITUTE OF DENTAL SCIENCES AND RESEARCH
Review of Medical Physiology 17 th edition, Willium Ganong ; DM Vasudevan Textbook of Biochemistry ,2 nd edition
FACTORS REGULATING BLOOD CALCIM LEVEL
(A) Vitamin D
The active form of vitamin D is called
dihydroxycholecalciferol or calcitriol. The
calcitriol induces a carrier protein in the
intestinal mucosa, which increases the
absorption of calcium. Hence blood
calcium level tends to be elevated.
Vitamin D is acting independently on
bone.
Vitamin D increases the number and
activity of osteoblasts, the bone forming
cells. Secretion of alkaline phosphatase
by osteoblasts is increased by vitamin D.
It is involved in minimizing the excretion
of calcium through kidney by decreasing
their excretion and enhancing
reabsorption.
Review of Medical Physiology 17 th edition, Willium Ganong ; DM Vasudevan Textbook of Biochemistry ,2 nd edition
(B) Parathyroid Hormone (PTH)
i. This hormone is secreted by the four parathyroid glands embedded in the thyroid tissue. The
chief cells of the gland secrete the PTH.
ii. The mature PTH has 84 amino acids. Storage of PTH is only for about 1 hour.
iii. Control of release of the hormone is by negative feedback by the ionized calcium in serum
Mechanism of action of PTH
i. PTH acts through cyclic AMP.
ii. PTH and bones: In the bone, PTH causes
demineralization or decalcification. It induces
pyrophosphatase in the osteoclasts. The
number of osteoclasts are also increased.
Osteoclasts release lactate into surrounding
medium which solubilizes calcium. PTH also
causes secretion of collagenase from osteoclasts.
This causes loss of matrix and bone resorption.
As a consequence, mucopolysaccharides and
hydroxyproline are excreted in urine.
iii. PTH and kidney: In kidney, PTH causes
decreased renal excretion of calcium and
increased excretion of phosphates. The action
is mainly through increase in reabsorption of
calcium from kidney tubules. It also targets
the 1α hydroxylase, whose function is to activate calcitriol.
Review of Medical Physiology 17 th edition, Willium Ganong ; DM Vasudevan Textbook of Biochemistry ,2 nd edition
(C) Calcitonin
i. It is secreted by the thyroid parafollicular or
clear cells. Calcitonin is a single chain
polypeptide. It contains about 32 amino
acids.
ii. Calcitonin secretion is stimulated by serum
calcium.
iii. Calcitonin level is increased in medullary
carcinoma of thyroid and therefore is a
tumor marker.
iv. Calcitonin decreases serum calcium level. It
inhibits resorption of bone. It decreases
the activity of osteoclasts and increases
that of osteoblasts.
v. Calcitonin and PTH are directly
Calcitonin, Calcitriol
antagonistic.The PTHand
andPTH Act Together
calcitonin
When blood promote
together calcium the
tends to lower,
bone growthPTH
and secretion is stimulated and calcitonin is
inhibited; bone demineralization leads to entry of more calcium into blood. When blood
remodelling.
calcium is increased, PTH is inhibited and calcitonin is secreted, causing more entry of
calcium into bone. Bone acts as the major reservoir of calcium.
DM Vasudevan Textbook of Biochemistry ,2nd edition
CONDITIONS ARISING FROM IRREGULARITIES IN
CALCIUM METABOLISM
1. Hypercalcemia
i. The term denotes that the blood calcium level is more
than 12 mg/dl. The major cause is hyper
parathyroidism .This may be due to a parathyroid
adenoma or an ectopic PTH secreting tumor.
ii. There is osteoporosis and bone resorption.
Pathological fracture of bone may result.
iii. In the blood, calcium and alkaline phosphatase
levels are increased, while phosphate level is lowered.
iv. In urine, calcium is excreted, which may cause
inhibition of elimination of chloride.
v. Calcium may be precipitated in urine, leading to
recurrent bilateral urinary calculi. Ectopic
calcification may be seen in renal tissue, pancreas
(pancreatitis), arterial walls, and muscle tissues
(myositis ossificans).
Signs and symtoms are- - stones (renal or biliary) -
bones(bone pain) -groans(abdominal pain, nausea,
vomiting) -thrones (polyuria) -psychiatric
Review of Medical Physiology 17 th edition, Willium Ganong ; DM Vasudevan Textbook of Biochemistry ,2 nd edition
overtones/moans(depression , anxiety)
2. Hypocalcemia and Tetany
i. When serum calcium level is less than 8.8 mg/ dl, it is hypocalcemia. If
serum calcium level is less than 8.5 mg/dl, there will be mild tremors. If it
is lower than 7.5 mg/dl, tetany, a lifethreatening condition will result.
ii. Tetany may be due to accidental surgical removal of parathyroid glands. Carpopedal spasm
iii. In tetany, neuromuscular irritability is increased. Main manifestations are
carpopedal spasm, laryngismus and stridulus. Laryngeal spasm may lead
to death.
iv. Clinical signs are Chvostek's sign (tapping over 5th cranial nerve causes
facial contraction) and Trousseau's sign (inflation of BP cuff causes
carpopedal spasm).
v. Serum calcium is lowered with corresponding increase in phosphate level.
Urinary excretion of both calcium and phosphate are decreased. Treatment
is to give intravenous injection of calcium salts.
Chvostek's sign
vi. It should be emphasized that vitamin D deficiency will not cause
tetany. The vitamin D deficiency causes rickets, where serum calcium Trousseau's sign
level is lowered marginally.
Etiologic factors:Decreased estrogen levels in postmenopausal women, Inactivity, Alcohol abuse, High phosphate diets,
Low calcium diets, Vit D deficiency, Corticosteroids, Smoking, Caffeine intake, Dietary protein imbalance, Stress.
Interleukin-1 and 6 also play important roles in the genesis of the condition.
It is the most prevalent metabolic bone disease that is associated with an increased risk for fractures (vertebra, hip and forearm).
Women above 50 years of age have a 40% risk for these fractures. The basic abnormality is decrease in bone mass, which attains a
peak by the age of 30 and starts declining by 35 to 45 years of age in both men and women. After the age of 45, calcium absorption is
reduced and calcium excretion is increased; so, there is net negative balance for calcium. This is reflected in demineralization. After
the age of 60, osteoporosis is seen. Then there is reduced bone strength and an increased risk of fractures.
Treatment – -Estrogen therapy remains controversial because of uncertainty about long-term benefits
-Vit D is another widely used therapeutic adjunct because of its important role in bone metabolism. Treatment is to give
calcium with vitamin D
-The most controversial experimental therapy is the use of fluoride. Fluoridic bone displays increased crystallinity, which
may actually result in decreased elasticity predisposing to fracture
-Increasing calcium intake by means of dairy foods & supplementation is the most practiced method in the prevention &
management of osteoporosis to optimize calcium balance
Calcium metabolism and osteoporotic ridge resorption, JPD, 1987 ; DM Vasudevan Textbook of Biochemistry ,2 nd edition
Osteoporosis and Residual Ridge Resorption (RRR):
RRR after tooth loss is a well described biological reaction. A
decrease in biomechanical loading on bone reduces the stresses
within the bone and results in resorption within the bone and
its periosteal surface. The single case control study seems to
indicate that the bone mineral content status in the jaws is
lower in patients with symptomatic osteoporosis than in
healthy age and menopausal age-matched females and that
osteoporosis may produce a risk factor for severe resorption of
the maxillary residual ridge, while this relationship is not clear
cut in the mandible. (Habets LLMH et al., 1998)
The effect of osteoporosis on dental treatments AUGUST 12, 2015 BY IMPLANT PRACTICE US
Complications caused by bisphonates:
• One of the most serious complications that have been related to the use of
bisphonates is the development of osteonecrosis of the jaws.
• To reduce the incidence of osteonecrosis before an implant surgery, risk
factors that increase the possibility of developing serious complications
should be identified such as
-smoking
-oral mucosal irritation associated to denture wearing
-periodontitis
-treatment with corticosteroids
-diabetes mellitus
• Furthermore, it is important to reduce the surgical trauma as much as
possible, to use abundant irrigation when drilling the bone, and to suture in
order to promote primary intention closure of the wound
A study was conducted on 5 edentulous patients. Branemark Ti. Unite 3. 75
mm diameter implants were used. Each patient recieved 6 control implants
and 1 bisphonate coated implant. In all the 5 patients, bisphonate implants
(Bisphonate-coated titanium screws as dental implants) had the highest
ISQ(Implant
Bisphosphonate Stability
coated titanium Quotient)
screws value.
as dental implants in patients. Per Aspenberg , Jahanmehr Abtahi, Pentti Tengvall.
Calcium phosphate coating on implants:
• Metal implants have been coated with layers of calcium
phosphates mainly composed of hydroxyapatite. Following
implantation, the release of calcium phosphate into the
peri-implant region increases the saturation of body fluids
and precipitates a biological apatite onto the surface of the
implant.
• This layer of biological apatite might contain endogenous
proteins and serve as a matrix for osteogenic cell attachment
and growth.
• The bone healing process around the implant is therefore
enhanced by this biological apatite layer.
• The biological fixation of titanium implants to bone tissue
is faster with a calcium phosphate coating than without.
Surface treatments of titanium dental implants for rapid osseointegration L. Le Guéhennec et al Dent mat , july 2007
Discussion regarding implant w.r.t osteoporosis :
• The available evidence on the risks associated with the treatment of
osteoporotic patients is poor and needs further investigation.
• Both the pathogenesis and the medications of osteoporosis can
interfere with the success of dental treatments involving osseous
healing of the jawbones.
• There is no absolute contraindication in placing dental implants in
osteoporotic patients, but a longer osseointegration healing period
should be taken into consideration. A correct patient selection is
also crucial.
• The association between BP use and osteonecrosis of the jaw
should not be overlooked.
• Attention should be paid to ensure an atraumatic surgical
technique, an adequate postoperative control, and an adequate
occlusal adjustment of the prosthesis.
CONCLUSION